BONE-MARROW STEM-CELL DISORDERS AND MITOLACTOL

被引：0

作者：

BELLET, RE

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1990年 / 8卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：751 / 751

页数：1

相关论文

共 3 条

[1]

BELLET RE, 1978, CANCER TREAT REP, V62, P2095

[2] MYELODYSPLASTIC SYNDROME AND ACUTE NONLYMPHOCYTIC LEUKEMIA SECONDARY TO MITOLACTOL TREATMENT IN PATIENTS WITH BREAST-CANCER [J].

FALKSON, G ;

GELMAN, RS ;

DREICER, R ;

TORMEY, DC ;

ALBERTS, AS ;

COCCIAPORTUGAL, MA ;

RUSHING, D ;

BENNETT, JM .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) :1252-1259

[3] A PHASE-II EVALUATION OF MITOLACTOL IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY [J].

STEHMAN, FB ;

BLESSING, JA ;

MCGEHEE, R ;

BARRETT, RJ .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) :1892-1895